Skip to main content
Clinical Trials/CTRI/2022/12/047901
CTRI/2022/12/047901
Not yet recruiting
Phase 3

A Hospital-Based Experimental Prospective Study To Compare The Efficacy Of Lycopene And Serratiopeptidase In The Management of Oral Submucous Fibrosis

HUMAIRA HUSSAI0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K135- Oral submucous fibrosis
Sponsor
HUMAIRA HUSSAI
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
HUMAIRA HUSSAI

Eligibility Criteria

Inclusion Criteria

  • For establishment of oral submucous fibrosis diagnosis, two parame\-ters mentioned below were to be satisfied for inclusion in the pre\-sent study\-
  • (a) Positive history of chewing areca nut or one of its commercial preparations, difficulty in swallowing and chewing and burning sen\-sation on eating spicy foods.
  • (b) Restricted mouth opening and changes in the oral mucous mem\-brane including the presence of palpable vertical fibrous bands, stiffness and blanching.

Exclusion Criteria

  • Individuals with other associated oral mucosal lesions or systemic diseases, systemic conditions like pregnancy, lactating mother and those not willing for follow\-up.

Outcomes

Primary Outcomes

Not specified

Similar Trials